Teva Pharms Inc Drug Patent Portfolio

Teva Pharms Inc owns 1 orange book drug protected by 1 US patent Given below is the list of Teva Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
Active


Teva Pharms Inc's Family Patents


Family Patents



Teva Pharms Inc Drug List

Given below is the complete list of Teva Pharms Inc's drugs and the patents protecting them.


1. Alvaiz

Alvaiz is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11072586 Solid state forms of eltrombopag choline 05 Nov, 2038
(13 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvaiz's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Teva Pharms Inc News

The US Supreme Court decides not to review patent clash involving popular Bausch diarrhea medication

18 Nov, 2024

Teva agrees to pay $450 million to settle kickback lawsuits related to MS drug Copaxone and generic medications

11 Oct, 2024

Business Wire releases a report on the United States market for generic drugs from 2024 to 2032, categorized by therapeutic area and type.

07 Aug, 2024

Analysis of the United States Market for Generic Drugs from 2024 to 2032, as per GlobeNewswire

06 Aug, 2024

See More